HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyoshi Hasegawa Selected Research

Etodolac (Lodine)

12/2013Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.
1/2012The effects of the selective cyclooxygenase-2 inhibitor on endometrial cytological findings in uterine endometrial cancer patients.
12/2011Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers.
5/2005Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyoshi Hasegawa Research Topics

Disease

107Neoplasms (Cancer)
09/2022 - 03/2002
71Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2003
53Neoplasm Metastasis (Metastasis)
10/2022 - 02/2003
15Fibrosis (Cirrhosis)
05/2022 - 02/2003
14Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 12/2009
13Hepatitis B
11/2019 - 01/2002
12Hepatitis
01/2016 - 01/2002
11Liver Neoplasms (Liver Cancer)
07/2022 - 06/2009
11Infections
08/2021 - 01/2002
11Endometrial Neoplasms (Endometrial Cancer)
01/2020 - 05/2005
10Carcinoma (Carcinomatosis)
01/2021 - 03/2003
9Cholangiocarcinoma
10/2022 - 12/2009
8Liver Failure
12/2021 - 09/2014
8Colorectal Neoplasms (Colorectal Cancer)
03/2021 - 01/2012
7Liver Diseases (Liver Disease)
05/2022 - 01/2002
7Hemorrhage
05/2022 - 02/2015
7Pathologic Constriction (Stenosis)
01/2021 - 04/2003
7Adenocarcinoma
01/2021 - 09/2010
7Hepatitis C
10/2017 - 01/2009
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 01/2011
6Portal Hypertension
11/2019 - 06/2008
5Thrombosis (Thrombus)
09/2021 - 01/2015
5End Stage Liver Disease
08/2021 - 12/2011
5Lymphatic Metastasis
11/2020 - 11/2007
5Ascites
08/2019 - 01/2009
5Massive Hepatic Necrosis
09/2004 - 01/2002
4Inflammation (Inflammations)
01/2022 - 01/2016
4Carcinogenesis
01/2021 - 06/2011
4Hypertrophy
06/2020 - 03/2006
4Body Weight (Weight, Body)
05/2019 - 08/2014
4Disease Progression
12/2018 - 09/2002
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
09/2014 - 07/2005
4Chronic Hepatitis B
07/2003 - 03/2002
3Bacterial Infections (Bacterial Infection)
05/2022 - 05/2016
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 03/2015
3Fistula
01/2022 - 07/2008
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2009
3Neoplasms, Cystic, Mucinous, and Serous
01/2021 - 08/2014
3Pain (Aches)
01/2021 - 08/2013
3Pancreatic Fistula (Pancreatic Fistulas)
11/2017 - 07/2008
3Acute Liver Failure (Fulminant Hepatic Failure)
01/2016 - 01/2002
3Thrombocytopenia (Thrombopenia)
11/2014 - 07/2010

Drug/Important Bio-Agent (IBA)

19Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2021 - 06/2009
14Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2003
10Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2002
10Messenger RNA (mRNA)IBA
01/2020 - 11/2004
8DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
8EnzymesIBA
01/2021 - 06/2005
8Tumor Biomarkers (Tumor Markers)IBA
09/2019 - 05/2008
7BilirubinIBA
05/2022 - 01/2002
7Biological ProductsIBA
01/2022 - 03/2003
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 02/2003
6AlbuminsIBA
08/2019 - 08/2009
6Prothrombin (Factor II)IBA
10/2015 - 01/2002
6acarboxyprothrombin (PIVKA)IBA
04/2014 - 08/2004
5SteroidsIBA
01/2017 - 01/2002
4Cetuximab (Erbitux)FDA Link
06/2022 - 07/2014
4UracilIBA
10/2021 - 10/2006
4TegafurIBA
10/2021 - 10/2006
4AntibodiesIBA
05/2021 - 03/2013
4MucinsIBA
01/2016 - 12/2009
4Etodolac (Lodine)FDA LinkGeneric
12/2013 - 05/2005
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2013 - 05/2005
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2009 - 01/2002
4Lamivudine (Epivir)FDA Link
07/2003 - 03/2002
3Cadherins (E-Cadherin)IBA
10/2022 - 01/2016
3Bevacizumab (Avastin)FDA Link
07/2022 - 08/2017
3ChromatinIBA
01/2022 - 01/2015
3Leucovorin (Folinic Acid)FDA Link
10/2021 - 02/2014
3Capsules (Microcapsules)IBA
04/2021 - 03/2018
3AcidsIBA
12/2020 - 08/2005
3Serum AlbuminIBA
06/2020 - 01/2019
3DiureticsIBA
05/2019 - 01/2009
3GemcitabineFDA Link
01/2019 - 01/2017
3GadoliniumIBA
11/2018 - 02/2018
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 01/2014
3AmylasesFDA Link
11/2017 - 11/2014
3PlatinumIBA
12/2015 - 11/2011
3Cisplatin (Platino)FDA LinkGeneric
01/2014 - 02/2009

Therapy/Procedure

55Liver Transplantation
07/2022 - 07/2003
53Hepatectomy
03/2022 - 02/2003
29Therapeutics
07/2022 - 01/2002
23Drug Therapy (Chemotherapy)
06/2022 - 02/2009
11Pancreaticoduodenectomy
03/2022 - 04/2003
9Transplantation
07/2022 - 11/2006
9Adjuvant Chemotherapy
10/2021 - 04/2007
7Operative Surgical Procedures
05/2022 - 08/2014
6Radiofrequency Ablation
04/2022 - 07/2010
4Photochemotherapy (Photodynamic Therapy)
02/2021 - 01/2014
4Stents
01/2021 - 01/2019
4Blood Transfusion (Blood Transfusions)
01/2019 - 12/2007
4Lasers (Laser)
10/2017 - 01/2014
3Neoadjuvant Therapy
09/2022 - 05/2018
3Pancreatectomy
03/2022 - 07/2008
3Laparoscopic Cholecystectomy
01/2022 - 07/2003
3Laparotomy
03/2021 - 01/2017
3Aftercare (After-Treatment)
01/2021 - 10/2016
3Metastasectomy
10/2020 - 09/2012
3Renal Dialysis (Hemodialysis)
06/2020 - 10/2017
3Contraindications
11/2019 - 06/2008